retatrutide clinical trial side effects FDA Approval Status 2026: Everything We Know So Far Retatrutide Phase 3 Trials Breakdown

That potency is precisely why supervision matters

10.1001/jama.1979.03300230018021 28 Aynsley-GreenA.AlbertiK

Source: Barrett, et al JAMA Surgery, September 17, 2025 Researchers correlated insurance claims data and electronic medical records in a system that owns both an insurance plan (Highmark) and a provider system (Allegheny Health), and compared total medical expense for over 30,000 individuals who had either metabolic and bariatric surgery (sleeve gastrectomy) or were treated with GLP-1 medications between 2018 and 2023

more reliable absorption than oral Challenge: Requires injection, carries infection risk if not sterile Bioavailability: Likely higher than oral but lower than intravenous Practical consideration: Not widely used in the community